Literature DB >> 12875587

Influence of roxithromycin on inflammatory cytokine production from nasal polyp fibroblasts in vitro.

Harumi Suzaki1, Kazuhito Asano, Mei Yu, Tadashi Hisamitsu.   

Abstract

The influence of macrolide antibiotics, roxithromycin (RXM) and josamycin (JM) on inflammatory cytokine production from human nasal polyp fibroblasts (NPFs) was examined using an in vitro cell culture technique. Addition of RXM at a concentration of 10.0 microg/ml to cell cultures suppressed both IL-6 and RANTES (but not IL-8) production in response to stimulation with 25.0 ng/ml tumor necrosis factor (TNF)-alpha. However, JM could not suppress IL-6, IL-8 and RANTES production from NPFs induced by TNF-alpha stimulation in vitro, even when added to cell cultures at a concentration of 20.0 microgram/ml. In the second part of the study, we examined the influence of RXM on cytokine mRNA expression in NPFs. Addition of RXM at a concentration of 10.0 mg/ml to cell cultures caused reduction of the mRNA expressions of both IL-6 and RANTES, which were enhanced by TNF-alpha stimulation in vitro.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12875587     DOI: 10.1080/0001648021000028132

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  4 in total

1.  Effects of Preoperative Clarithromycin Administration in Patients with Nasal Polyposis.

Authors:  A Perić; N Baletić; M Milojević; J Sotirović; L Živić; A V Perić; D Vojvodić
Journal:  West Indian Med J       Date:  2015-03-20       Impact factor: 0.171

2.  Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein.

Authors:  M von Lilienfeld-Toal; M P Dietrich; A Glasmacher; L Lehmann; P Breig; C Hahn; I G H Schmidt-Wolf; G Marklein; S Schroeder; F Stuber
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-06-22       Impact factor: 3.267

3.  Suppressive activity of tiotropium bromide on matrix metalloproteinase production from lung fibroblasts in vitro.

Authors:  Kazuhito Asano; Yusuke Shikama; Yasuhiro Shibuya; Hiroaki Nakajima; Ken-ichi Kanai; Naohiro Yamada; Harumi Suzaki
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

4.  Suppression of matrix metalloproteinase production in nasal fibroblasts by tranilast, an antiallergic agent, in vitro.

Authors:  Toshiyuki Shimizu; Kenichi Kanai; Kazuhito Asano; Tadashi Hisamitsu; Harumi Suzaki
Journal:  Mediators Inflamm       Date:  2005-08-14       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.